513 related articles for article (PubMed ID: 11597033)
1. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
McIntyre CW; Fluck RJ; Lambie SH
Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
[TBL] [Abstract][Full Text] [Related]
2. Treatment of vasculitic IgA nephropathy.
Harper L; Ferreira MA; Howie AJ; Savage CO; Richards NT; Michael J; Adu D
J Nephrol; 2000; 13(5):360-6. PubMed ID: 11063140
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
Tsuruya K; Harada A; Hirakata H; Mitsuiki K; Johko T; Kondoh H; Takechi S; Fujishima M
Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476
[TBL] [Abstract][Full Text] [Related]
5. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
[TBL] [Abstract][Full Text] [Related]
6. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
7. Can immunosuppressive drugs slow the progression of IgA nephropathy?
Goumenos D; Ahuja M; Shortland JR; Brown CB
Nephrol Dial Transplant; 1995; 10(7):1173-81. PubMed ID: 7478120
[TBL] [Abstract][Full Text] [Related]
8. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
[TBL] [Abstract][Full Text] [Related]
9. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
[TBL] [Abstract][Full Text] [Related]
10. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
Uzu T; Harada T; Ko M; Yamato M; Takahara K; Yamauchi A
Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
[TBL] [Abstract][Full Text] [Related]
11. [Effects of methylprednisolone pulse therapy on progressive IgA nephropathy].
Yoshimura M; Kida H; Saito Y; Takaeda M; Sugioka G
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):761-8. PubMed ID: 1770636
[TBL] [Abstract][Full Text] [Related]
12. [The course and prognosis of mesangioproliferative glomerulonephritis].
Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone.
Eriguchi M; Oka H; Mizobuchi T; Kamimura T; Sugawara K; Harada A
Nephrol Dial Transplant; 2009 Oct; 24(10):3082-8. PubMed ID: 19465558
[TBL] [Abstract][Full Text] [Related]
14. Effective treatment administration of cyclophosphamide in membranous nephropathy.
Dede F; Ayili D; Sahiner S
J Nephrol; 2008; 21(4):560-5. PubMed ID: 18651546
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial.
Lai KN; Lai FM; Ho CP; Chan KW
Clin Nephrol; 1986 Oct; 26(4):174-80. PubMed ID: 3536231
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive treatment of Berger's disease.
Faedda R; Pirisi M; Satta A; Bosincu L; Bartoli E
Clin Pharmacol Ther; 1996 Nov; 60(5):561-7. PubMed ID: 8941029
[TBL] [Abstract][Full Text] [Related]
18. Combined therapy in children and adolescents with IgA nephropathy.
Murakami K; Yoshioka K; Akano N; Takemura T; Okada M; Aya N; Hino S; Miyazato H; Yagi K; Maki S
Nihon Jinzo Gakkai Shi; 1994 Jan; 36(1):38-43. PubMed ID: 8107307
[TBL] [Abstract][Full Text] [Related]
19. Vasculitic IgA nephropathy: prognosis and outcome.
Pankhurst T; Lepenies J; Nightingale P; Howie AJ; Adu D; Harper L
Nephron Clin Pract; 2009; 112(1):c16-24. PubMed ID: 19342865
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]